BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT05223816-completion@plaintrial.com
DTSTAMP:20261028T172749Z
DTSTART;VALUE=DATE:20251231
SUMMARY:An Open-Label\, Multiple-Center\, Phase IIa/IIb Clinical Trial to E
 valuate the Efficacy\, Safety and Tolerability of VG161 as Monotherapy and
  in Combination With Nivolumab for Treatment of Patients With Hepatocellul
 ar Carcinoma or Intrahepatic Cholangiocarcinoma — estimated completion d
 ate
DESCRIPTION:Recruiting. Saved on your PlainTrial shortlist. Full trial reco
 rd: https://plaintrial.com/trial/NCT05223816
URL:https://plaintrial.com/trial/NCT05223816
END:VEVENT
END:VCALENDAR